The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

University Hospitals Urology Institute is using a new technique to diagnose prostate cancer through a method that allows the urologist to obtain a prostate biopsy with a lower risk of introducing ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A ...

From University Hospitals: The University Hospitals (UH) Urology Institute is the first in Northeast Ohio to use a new technique to diagnose prostate cancer. The method allows the urologist to obtain ...

A large randomized trial conducted at Tampere University and the University of Helsinki shows that a new three-step prostate cancer screening method can find a considerable number of aggressive ...

Dr Ray O’Connor takes a look at recent clinical articles on screening, particularly with respect to cervical and prostate ...

This study examined changes in prostate disease screening (prostatic-specific antigen [PSA] testing), prostate biopsy testing, and prostate cancer diagnoses during the COVID-19 pandemic through ...

In a randomized trial of prostate cancer screening methods, a blood-based diagnostic test and MRI with subsequent targeted plus systematic prostate biopsies outperformed the standard approach of ...

A prostate biopsy is a procedure to remove small samples of tissue from the prostate gland. It's a method to test for prostate cancer if a prostate-specific antigen (PSA) blood test or digital rectal ...

Transrectal ultrasound guided (TRUS) biopsy has been the gold standard for prostate cancer diagnosis, but carries a significant risk of urinary tract infection, sometimes requiring hospital admission ...